Lastly, the cohort included one patient with Gaucher disease that was not detected based on metabolite assays but based on enzymatic screening (abnormal plasma chitotriosidase and dried blood spot glucocerebrosidase activity). This evidence concerns the gene GBA1 and Gaucher disease.